Activity of the amidoamine myristamidopropyl dimethylamine against keratitis pathogens

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 6, 2003, Pages 1415-1418

  Hughes, Reanne ^a   Dart, John ^b   Kilvington, Simon ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Acanthamoeba; Amidoamine; Antibacterial; Antifungal; Keratitis

Indexed keywords

AMIDOAMINE MYRISTAMIDOPROPYL DIMETHYLAMINE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; DIMETHYLAMINE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; CORNEA SURGERY; DRUG EFFICACY; FUSARIUM SOLANI; INFECTION PREVENTION; KERATITIS; NONHUMAN; PROVOCATION TEST; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ACANTHACEAE; ACANTHAMOEBA KERATITIS; ANTI-INFECTIVE AGENTS; BACTERIA; FUNGI; HUMANS; KERATITIS; PROPYLAMINES; SOLUTIONS;

EID: 0038308853     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg259     Document Type: Article

References (12)

1. Anonymous. (1979). Data on blindness throughout the world. World Health Organisation Chronicle 33, 275-83.
2. Srinivasan, M., Gonzales, C. A., George, C., Cevallos, V., Mascarenhas, J. M., Asokan, B. et al. (1997). Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. British Journal of Ophthalmology 81, 965-71.
3. Dart, J. K. G., Stapleton, F. & Minassian, D. (1991). Contact lenses and other risk factors in microbial keratitis. Lancet 338, 650-3.
4. Boonapasart, S., Kasetsuwan, N., Puangsricharem, V., Pariyakanok, L. & Jittpoonkusol, T. (2002). Infectious keratitis at King Chulalonghorn Memorial Hospital: a 12 year retrospective study of 391 cases. Journal of the Medical Association of Thailand 85, Suppl. 1, S217-30.
5. Gopinathan, U., Garg, P., Fernandes, M., Sharma, S., Athmanathan, S. & Rao, G. N. (2002). The epidemiological features and laboratory results of fungal keratitis: a 10 year review at a referral eye care center in South India. Cornea 21, 555-9.
6. Kilvington, S., Hughes, R., Byas, J. & Dart, J. (2002). Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrobial Agents and Chemotherapy 46, 2007-9.
7. International Organization for Standardization. (2001). Ophthalmic optics-contact lens care products-microbiological requirements and test methods for products and regimens for hygienic management of contact lenses. ISO/CD 14729. International Organization for Standardization, Geneva, Switzerland.
8. Hughes, R. & Kilvington, S. (2001). Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrobial Agents and Chemotherapy 45, 2038-43.
9. McLeod, S. D., Kolahdouz-Isfahani, A., Rostamian, K., Flowers, C. W., Lee, P. P. & McDonnell, P. J. (1996). The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology 103, 23-8.
10. Ciulla, T. A., Starr, M. B. & Masket, S. (2002). Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence based update. Ophthalmology 109, 13-24.
11. Rahman, M. R., Johnson, G. J., Husain, R., Howlader, S. A. & Minassian, D. C. (1998). Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. British Journal of Ophthalmology 82, 919-25.
12. Chawner, J. A. & Gilbert, P. (1989). Interaction of the bisbiguanides chlorhexidine and alexidine with phospholipid vesicles; evidence for separate modes of action. Journal of Applied Bacteriology 66, 253-8.